---
title: "CENTESSA PHARMACEUTICALS (UK) LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/49b4bbab-6596-5297-9c2a-d9bb6ed51b20
json: https://whiteintel.dev/api/public/dossier/49b4bbab-6596-5297-9c2a-d9bb6ed51b20
identifier: oo:GB-COH-13040752
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# CENTESSA PHARMACEUTICALS (UK) LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-13040752`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/49b4bbab-6596-5297-9c2a-d9bb6ed51b20  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/49b4bbab-6596-5297-9c2a-d9bb6ed51b20  

## Ownership & control

### Owners / controllers

- **CENTESSA PHARMACEUTICALS PLC** (beneficial owner) — 100% — https://whiteintel.dev/entity/e10d05fd-7fc1-5145-a4ed-00f5510bea05
- **CENTESSA PHARMACEUTICALS PLC** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/e10d05fd-7fc1-5145-a4ed-00f5510bea05

### Holdings / subsidiaries

- **Z FACTOR LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/cb319fa4-52b2-559b-99a4-fd356a2e1225
- **APCINTEX LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/1ce75cc1-1a3d-58e3-b6a9-7c8aed88af8a
- **Z FACTOR LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/cb319fa4-52b2-559b-99a4-fd356a2e1225

### UBO chain (walk to the ultimate owner)

A **4-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `13040752`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2020-11-24
- **Registered office:** Lilly House Basingview, Basingstoke, Hampshire, RG21 4FA, United Kingdom
- **SIC:** 72110

### Officers

- [OAKWOOD CORPORATE SECRETARY LIMITED](https://whiteintel.dev/entity/1c359d14-ce8b-42da-aba0-13fad1c329e5) — corporate secretary · appointed 2021-04-29
- STOKES, Christopher J — director · American · appointed 2026-06-24
- WRIGHT, Kristina Mignon — director · American · appointed 2026-06-24
- TAIT, Nicholas Alexander James — secretary · appointed 2020-11-24 · resigned 2021-04-20
- CHAO, David Min — director · American · appointed 2023-08-17 · resigned 2025-07-04
- DE RUBERTIS, Francesco — director · Italian · appointed 2020-12-04 · resigned 2021-02-19
- HUSSAIN, Iqbal — director · British · appointed 2021-02-19 · resigned 2026-06-24
- LEE, Richard Michael — director · British · appointed 2020-11-24 · resigned 2021-02-19
- MENZIUSO, Richard — director · American · appointed 2022-11-10 · resigned 2026-06-24
- SAHA, Saurabh, Dr — director · American · appointed 2021-02-19 · resigned 2022-11-10
- THORELL, Marella — director · American · appointed 2021-02-19 · resigned 2022-07-31
- WEINHOFF, Gregory Mark — director · American · appointed 2025-07-01 · resigned 2026-06-24
- YUE, Patrick — director · American · appointed 2023-08-17 · resigned 2024-06-21

### Beneficial owners (Persons with Significant Control)

- [Centessa Pharmaceuticals Plc](https://whiteintel.dev/entity/e10d05fd-7fc1-5145-a4ed-00f5510bea05) — 75–100% shares · corporate PSC · United Kingdom — since 2020-11-24

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/13040752
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/13040752

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **CENTESSA PHARMACEUTICALS (UK) LIMITED** — https://whiteintel.dev/entity/49b4bbab-6596-5297-9c2a-d9bb6ed51b20 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **CENTESSA PHARMACEUTICALS (UK) LIMITED**. Human view: https://whiteintel.dev/entity/49b4bbab-6596-5297-9c2a-d9bb6ed51b20 · Structured JSON: https://whiteintel.dev/api/public/dossier/49b4bbab-6596-5297-9c2a-d9bb6ed51b20._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._